Previous 10 | Next 10 |
2023-03-27 15:26:39 ET Deutsche Bank has upgraded Novartis ( NYSE: NVS ) to hold from sell saying that positive top-line results of a phase 3 trial of its breast cancer drug Kisqali (ribociclib) released earlier Monday were a surprise. The firm has a price target of CH...
2023-03-27 11:49:44 ET Stocks climbed in Monday's midday session, led by rebounds in regional banks followed by SVB deal . Looking at the individual stocks, Roku ( NASDAQ: ROKU ) and Pinterest ( NYSE: PINS ) were higher on an analyst upgrade, whereas Caterpillar ...
2023-03-27 05:46:33 ET Novartis ( NYSE: NVS ) shares surged 6% premarket on Monday after the pharmaceutical firm reported positive topline results from its highly awaited Natalee breast cancer trial . Natalee is a global Phase III multi-center, randomized, open-label t...
2023-03-27 05:45:26 ET The shares of Dutch biotech Pharming Group N.V. ( NASDAQ: PHAR ) added ~24% on Monday in the Amsterdam stock exchange on the announcement of U.S. approval for the rare immune disorder therapy Joenja co-developed with Novartis ( NVS ). The FDA...
2023-03-24 17:46:35 ET Summary Dimensional International Value ETF is an actively managed fund investing in value stocks outside the U.S. Almost 30% of DFIV assets are in financials. Otherwise, it is well-diversified across countries and holdings. DFIV is slightly better t...
2023-03-23 14:33:09 ET As the US has been dealing with shortages of key drugs, the White House has unveiled a report that aims to spur US biomanufacturing production. Goals set in the report include producing at least 30% of the country's biochemical demand in the with sustainable bioma...
2023-03-23 14:00:00 ET Summary In today’s article, I will present 10 dividend growth companies that I currently consider to be particularly attractive. The 10 selected picks have shown an Average Dividend Growth Rate of 12.92% over the past 5 years. At the same time, th...
2023-03-22 12:45:19 ET Novartis ( NYSE: NVS ) and Roche ( OTCQX:RHHBY ) unit Genentech are touting long-term data for their respective spinal muscular atrophy ( SMA ) treatments. Novartis ( NVS ) said that data from a trial on its one-time gene therapy Zolgensm...
2023-03-22 05:43:34 ET Novartis ( NYSE: NVS ) has chosen not to go ahead with a U.K.-based main prevention trial called ORION-17, of its anti-cholesterol therapy Leqvio, which was planned as part of its collaboration with U.K.'s National Health Service (NHS) to evalu...
2023-03-22 04:40:44 ET The U.S. Food and Drug Administration (FDA) approved Novartis' ( NYSE: NVS ) citrate-free high-concentration formulation (HCF) of Hyrimoz, a biosimilar to AbbVie's ( NYSE: ABBV ) blockbuster drug Humira. Hyrimoz (adalim...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...